Annual Net Income
-$89.22 M
-$23.00 M-34.73%
December 31, 2023
Summary
- As of February 7, 2025, TCRX annual net profit is -$89.22 million, with the most recent change of -$23.00 million (-34.73%) on December 31, 2023.
- During the last 3 years, TCRX annual net income has fallen by -$63.09 million (-241.48%).
- TCRX annual net income is now -553.23% below its all-time high of -$13.66 million, reached on December 31, 2019.
Performance
TCRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$29.89 M
+$1.77 M+5.60%
September 30, 2024
Summary
- As of February 7, 2025, TCRX quarterly net profit is -$29.89 million, with the most recent change of +$1.77 million (+5.60%) on September 30, 2024.
- Over the past year, TCRX quarterly net income has dropped by -$6.89 million (-29.96%).
- TCRX quarterly net income is now -439.77% below its all-time high of -$5.54 million, reached on March 31, 2020.
Performance
TCRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$111.30 M
-$6.89 M-6.60%
September 30, 2024
Summary
- As of February 7, 2025, TCRX TTM net profit is -$111.30 million, with the most recent change of -$6.89 million (-6.60%) on September 30, 2024.
- Over the past year, TCRX TTM net income has dropped by -$22.98 million (-26.01%).
- TCRX TTM net income is now -1910.17% below its all-time high of -$5.54 million, reached on March 31, 2020.
Performance
TCRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
TCRX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.7% | -30.0% | -26.0% |
| 3 y3 years | -241.5% | -30.0% | -26.0% |
| 5 y5 years | -553.2% | -30.0% | -26.0% |
TCRX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -83.5% | at low | -110.5% | +5.6% | -128.9% | at low |
| 5 y | 5-year | -553.2% | at low | -439.8% | +5.6% | -1910.2% | at low |
| alltime | all time | -553.2% | at low | -439.8% | +5.6% | -1910.2% | at low |
TScan Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$29.89 M(-5.6%) | -$111.30 M(+6.6%) |
| Jun 2024 | - | -$31.66 M(+5.0%) | -$104.41 M(+7.9%) |
| Mar 2024 | - | -$30.14 M(+53.7%) | -$96.80 M(+8.5%) |
| Dec 2023 | -$89.22 M(+34.7%) | -$19.61 M(-14.7%) | -$89.22 M(+1.0%) |
| Sep 2023 | - | -$23.00 M(-4.4%) | -$88.33 M(+8.3%) |
| Jun 2023 | - | -$24.05 M(+6.6%) | -$81.58 M(+12.3%) |
| Mar 2023 | - | -$22.56 M(+20.5%) | -$72.63 M(+9.7%) |
| Dec 2022 | -$66.22 M | -$18.72 M(+15.3%) | -$66.22 M(+7.3%) |
| Sep 2022 | - | -$16.25 M(+7.6%) | -$61.70 M(+0.7%) |
| Jun 2022 | - | -$15.10 M(-6.6%) | -$61.29 M(+7.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$16.16 M(+13.8%) | -$56.87 M(+17.0%) |
| Dec 2021 | -$48.63 M(+86.1%) | -$14.20 M(-10.3%) | -$48.63 M(+15.1%) |
| Sep 2021 | - | -$15.84 M(+48.4%) | -$42.23 M(+25.8%) |
| Jun 2021 | - | -$10.67 M(+34.9%) | -$33.56 M(+17.8%) |
| Mar 2021 | - | -$7.91 M(+1.3%) | -$28.50 M(+9.1%) |
| Dec 2020 | -$26.13 M(+91.3%) | - | - |
| Dec 2020 | - | -$7.81 M(+8.9%) | -$26.13 M(+42.6%) |
| Sep 2020 | - | -$7.17 M(+27.7%) | -$18.32 M(+64.3%) |
| Jun 2020 | - | -$5.61 M(+1.4%) | -$11.15 M(+101.4%) |
| Mar 2020 | - | -$5.54 M | -$5.54 M |
| Dec 2019 | -$13.66 M | - | - |
FAQ
- What is TScan Therapeutics annual net profit?
- What is the all time high annual net income for TScan Therapeutics?
- What is TScan Therapeutics annual net income year-on-year change?
- What is TScan Therapeutics quarterly net profit?
- What is the all time high quarterly net income for TScan Therapeutics?
- What is TScan Therapeutics quarterly net income year-on-year change?
- What is TScan Therapeutics TTM net profit?
- What is the all time high TTM net income for TScan Therapeutics?
- What is TScan Therapeutics TTM net income year-on-year change?
What is TScan Therapeutics annual net profit?
The current annual net income of TCRX is -$89.22 M
What is the all time high annual net income for TScan Therapeutics?
TScan Therapeutics all-time high annual net profit is -$13.66 M
What is TScan Therapeutics annual net income year-on-year change?
Over the past year, TCRX annual net profit has changed by -$23.00 M (-34.73%)
What is TScan Therapeutics quarterly net profit?
The current quarterly net income of TCRX is -$29.89 M
What is the all time high quarterly net income for TScan Therapeutics?
TScan Therapeutics all-time high quarterly net profit is -$5.54 M
What is TScan Therapeutics quarterly net income year-on-year change?
Over the past year, TCRX quarterly net profit has changed by -$6.89 M (-29.96%)
What is TScan Therapeutics TTM net profit?
The current TTM net income of TCRX is -$111.30 M
What is the all time high TTM net income for TScan Therapeutics?
TScan Therapeutics all-time high TTM net profit is -$5.54 M
What is TScan Therapeutics TTM net income year-on-year change?
Over the past year, TCRX TTM net profit has changed by -$22.98 M (-26.01%)